1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Animal Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. North America Animal Healthcare Market, by Animal Type
8.1.1. Production Animal
8.1.1.1. Market Revenue and Forecast
8.1.2. Companion Animal
8.1.2.1. Market Revenue and Forecast
9.1. North America Animal Healthcare Market, by Product Type
9.1.1. Vaccines
9.1.1.1. Market Revenue and Forecast
9.1.2. Pharmaceuticals
9.1.2.1. Market Revenue and Forecast
9.1.3. Feed Additives
9.1.3.1. Market Revenue and Forecast
9.1.4. Diagnostics
9.1.4.1. Market Revenue and Forecast
9.1.5. Equipment and Disposables
9.1.5.1. Market Revenue and Forecast
9.1.6. Others
9.1.6.1. Market Revenue and Forecast
10.1. North America Animal Healthcare Market, by Distribution Channel Type
10.1.1. Retail Pharmacy
10.1.1.1. Market Revenue and Forecast
10.1.2. E-commerce
10.1.2.1. Market Revenue and Forecast
10.1.3. Hospital Pharmacy
10.1.3.1. Market Revenue and Forecast
11.1. North America Animal Healthcare Market, by End Use Type
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast
11.1.2. Point of care testing/ in-house testing
11.1.2.1. Market Revenue and Forecast
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. North America Animal Healthcare Market, by Treatments
12.1.1. Allergies
12.1.1.1. Market Revenue and Forecast
12.1.2. Arthritis
12.1.2.1. Market Revenue and Forecast
12.1.3. Gastrointestinal Disease
12.1.3.1. Market Revenue and Forecast
12.1.4. Difficult Dermatology Cases
12.1.4.1. Market Revenue and Forecast
12.1.5. Others
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal
13.1.2. Market Revenue and Forecast, by Product
13.1.3. Market Revenue and Forecast, by Distribution Channel
13.1.4. Market Revenue and Forecast, by End Use
13.1.5. Market Revenue and Forecast, by Treatments
14.1. Elanco
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bayer
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Dechra Pharmaceuticals
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Neogen
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Boehringer Ingelheim
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Merck & Co, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Zoetis
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nutreco N.V.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Virbac
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Vetquinol S.A.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
